SCI Abstract

search
+
Chapter One - Neuroanatomy of the nociceptive system: From nociceptors to brain networks
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Two - Neuropathic pain – A clinical primer
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Three - Quantitative Sensory Testing – From bench to bedside
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Four - Regional and interregional functional and structural brain abnormalities in neuropathic pain
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Five - Clinical neurophysiology of neuropathic pain
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Six - Placebo effects in neuropathic pain conditions
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Seven - Small fiber neuropathy
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Eight - Modeling neuropathic pain in a dish
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Nine - Molecular mechanisms of neuropathic pain
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Ten - Exploring neuroinflammation: A key driver in neuropathic pain disorders
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Eleven - Animal models of neuropathic pain
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Twelve - Clinical pharmacology of neuropathic pain
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Thirteen - Psychological, physical and complementary therapies for the management of neuropathic pain
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Chapter Fourteen - Neuromodulation for neuropathic pain
Update your browser to view ScienceDirect correctly. Your technical details and browser version: Request ID: 90efe...
Setting the clinical context to non-motor symptoms reflected by Park-pain, Park-sleep, and Park-autonomic subtypes of Parkinson’s disease
Setting the clinical context to non-motor symptoms reflected by Park-pain, Park-sleep, and Park-autonomic subtypes of Parkinson’s disease
Dr James Parkinson, in 1817, first described a condition based on observation of motor features ranging from shaking to po...
Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson’s disease
Macro and micro-sleep dysfunctions as translational biomarkers for Parkinson’s disease
Parkinson’s disease (PD) is the second most common neurodegenerative disease, afflicting about 1% of people over 65 years ...
Half Title Page
Half Title Page
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Series Page
Series Page
We use cookies to help provide and enhance our service and tailor content and ads. By continuing you agree to the use of c...
Chapter One - The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence
Chapter One - The dopamine hypothesis of autism spectrum disorder: A comprehensive analysis of the evidence
Autism spectrum disorder (ASD) remains a public health concern, as recent prevalence estimates of ASD are as high as 1 in ...
Chapter Two - A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders
Chapter Two - A review of the use of psychotropic medication to address challenging behaviour in neurodevelopmental disorders
Engagement in challenging behaviour (e.g., aggression, self-injury) is reported to occur in neurodevelopmental disorders s...
Chapter Three - Involvement of brain metabolism in neurodevelopmental disorders
Chapter Three - Involvement of brain metabolism in neurodevelopmental disorders
Metabolism represents a series of biochemical pathways that provide cells with solutions to utilize and produce energy, to...
Chapter Four - Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders
Chapter Four - Cholesterol alterations in fragile X syndrome, autism spectrum disorders and other neurodevelopmental disorders
Autism spectrum disorder (ASD) refers to a group of neurodevelopmental disorders that manifests during early childhood. AS...
Chapter Five - Toward an understanding of the role of the exposome on fragile X phenotypes
Chapter Five - Toward an understanding of the role of the exposome on fragile X phenotypes
Fragile X syndrome (FXS) is the leading known monogenetic cause of autism with an estimated 21–50% of FXS individuals meet...
Chapter Six - How dendritic spines shape is determined by MMP-9 activity in FXS
Chapter Six - How dendritic spines shape is determined by MMP-9 activity in FXS
Fragile X syndrome (FXS) is the leading inherited intellectual disability and the most prevalent single-gene cause of auti...
Chapter Seven - Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome
Chapter Seven - Glial-mediated dysregulation of neurodevelopment in Fragile X Syndrome
Since the discovery of the genetic mutation in Fragile X Syndrome (FXS) and the resulting absence of the fragile X messeng...
How dendritic spines shape is determined by MMP-9 activity in FXS
How dendritic spines shape is determined by MMP-9 activity in FXS
Fragile X syndrome (FXS) is the leading inherited intellectual disability and the most prevalent single-gene cause of auti...
Chapter One - Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha
Chapter One - Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha
Spinal cord injury across the World is one of the prominent causes of disability in military as well as the civilians for ...
Chapter Two - Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury
Chapter Two - Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury
Spinal cord injury cases worldwide are about 50–80 per million population largely affecting males during traffic accidents...
Chapter Three - Neuromodulation and quality of life for patient with spasticity after spinal cord injury
Chapter Three - Neuromodulation and quality of life for patient with spasticity after spinal cord injury
Advances of the modern medicine require reconceptualization of the existing approaches to therapy of neurological diseases...
Chapter Four - Efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease: Nanodelivery and enriched environment
Chapter Four - Efficacy of invasive and non-invasive methods for the treatment of Parkinson’s disease: Nanodelivery and enriched environment
Parkinson’s disease (PD) is the most common neurodegenerative disorder after Alzheimer’s disease, affecting 1–2% of the po...
Load More
format_indent_increase